Replies to post #1182 on Exelixis Inc (EXEL)

[TwoPack]

Sold EXEL @ $5.05 yesterday -- looking to re-enter

I missed that flash in the pan, didn't expect such a run to the lip of the cup (--> 'cup and handle' pattern) before EXEL possibly goes back below $5 (one more and last time?) and starts building the handle of the cup:

more than 20 cents down AH doubtless because of this:

FDA Approves Eisai's LENVIMA® (lenvatinib) for the Treatment of Patients with Advanced Renal Cell Carcinoma in Combination with Everolimus Following Prior Anti-Angiogenic Therapy

Eisai mediaroom